{"doi":"10.2337/diab.45.3.s65","title":"Recent Progress in Advanced Glycation and Diabetic Vascular Disease: Role of Advanced Glycation End Product Receptors","abstract":"<jats:p>Advanced glycosylation end products (AGEs) form principally from the rearrangement of early glycation products, i.e., Amadori products, which produce a class of stable moieties that possess distinctive chemical cross-linking and biological properties. It has been generally believed that proteins with half-lives of longer than a few weeks are most susceptible to advanced glycosylation and that the highest levels of AGEs occur on proteins that comprise the long-lived structural components of connective tissue matrix and basement membrane.</jats:p>","journal":"Diabetes","year":1996,"id":25117,"datarank":6.194274066241915,"base_score":4.770684624465665,"endowment":4.770684624465665,"self_citation_contribution":0.7156026936698499,"citation_network_contribution":5.478671372572065,"self_endowment_contribution":0.7156026936698499,"citer_contribution":5.478671372572065,"corpus_percentile":null,"corpus_rank":null,"citation_count":117,"citer_count":113,"citers_with_citation_signal":101,"citers_with_endowment":101,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":null,"is_oa":false,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":79005,"name":"Richard Bucala","orcid":"0000-0001-5783-5736","position":1,"is_corresponding":false},{"id":148640,"name":"Helen Vlassara","orcid":null,"position":0,"is_corresponding":false}],"reference_count":0,"raw_metadata":{"has_enrichment":true,"base_score":4.770684624465665,"endowment":4.770684624465665,"datacite_reuse_total":0,"file_count":0,"downloads":0,"views":0,"has_version_chain":false,"is_dataset":false,"is_oa":false,"pmid":"8674896","pmcid":null,"openalex_id":"https://openalex.org/W2129049321","authors":[],"funders":[],"total_grants":0,"fwci":5.7956,"citation_percentile":0.9658606,"influential_citations":3,"citation_trend":[{"year":2012,"count":3},{"year":2013,"count":5},{"year":2014,"count":7},{"year":2015,"count":6},{"year":2016,"count":3},{"year":2017,"count":3},{"year":2018,"count":7},{"year":2020,"count":3},{"year":2021,"count":1},{"year":2022,"count":3},{"year":2023,"count":1},{"year":2024,"count":1},{"year":2026,"count":1}],"oa_status":"closed","license":null,"oa_locations":[{"url":"https://journals.org/diabetes/diabetes/article-pdf/45/Supplement_3/S65/362874/45-3-s65.pdf","host_type":"publisher"},{"url":"https://diabetesjournals.org/diabetes/article-pdf/45/Supplement_3/S65/362874/45-3-s65.pdf","host_type":"publisher"},{"url":"https://doi.org/10.2337/diab.45.3.s65","host_type":"journal"},{"url":"https://pubmed.ncbi.nlm.nih.gov/8674896","host_type":"repository"}],"fields_of_study":["Advanced Glycation End Products research","Natural Antidiabetic Agents Studies","Neurological Disorders and Treatments","Chemistry","Medicine","Animals","Diabetic Angiopathies","Glycation End Products, Advanced","Humans","Receptor for Advanced Glycation End Products","Receptors, Immunologic"],"mesh_terms":["Receptor for Advanced Glycation End Products","Animals","Diabetic Angiopathies","Humans","Receptors, Immunologic","Glycation End Products, Advanced"],"keywords":["Glycation","Amadori rearrangement","Advanced glycation end-product","Glycosylation","Chemistry","Receptor","Biochemistry","Lysine","Cell biology","Biology","Amino acid"],"sdg_mappings":[{"sdg_number":0,"sdg_label":"Good health and well-being"}],"linked_datasets":[],"clinical_trials":[],"software_tools":[],"database_accessions":[],"source":"live","citation_network_status":"fetched"},"created_at":"2026-06-08T00:07:16.997825Z","pmid":null,"pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}